Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8933 |
High Similarity |
NPD4965 |
Approved |
0.8933 |
High Similarity |
NPD4967 |
Phase 2 |
0.8933 |
High Similarity |
NPD4966 |
Approved |
0.8816 |
High Similarity |
NPD6234 |
Discontinued |
0.8733 |
High Similarity |
NPD37 |
Approved |
0.8523 |
High Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8462 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8428 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8354 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.8221 |
Intermediate Similarity |
NPD7240 |
Approved |
0.82 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7986 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7964 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7591 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7578 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7556 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7552 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7551 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7532 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7531 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7528 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.75 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7465 |
Intermediate Similarity |
NPD17 |
Approved |
0.7423 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7415 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7381 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7365 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7362 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7353 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7351 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD919 |
Approved |
0.7329 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7326 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7294 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7285 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7267 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7254 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7251 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7241 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7239 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7237 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7237 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7213 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7213 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7208 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7205 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7202 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7195 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7195 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7195 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7193 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7191 |
Intermediate Similarity |
NPD7296 |
Approved |
0.7179 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7178 |
Intermediate Similarity |
NPD6385 |
Approved |
0.717 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7168 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7152 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7125 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7125 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7125 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7117 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.711 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7091 |
Intermediate Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7089 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7089 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7088 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7081 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7069 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7067 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7059 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7053 |
Intermediate Similarity |
NPD7827 |
Phase 1 |
0.7051 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7051 |
Intermediate Similarity |
NPD2531 |
Phase 2 |
0.7044 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7041 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7041 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7034 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7034 |
Intermediate Similarity |
NPD1651 |
Approved |
0.702 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7019 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD3146 |
Approved |
0.7018 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7018 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.6988 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD3750 |
Approved |
0.6974 |
Remote Similarity |
NPD7095 |
Approved |
0.697 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6948 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6946 |
Remote Similarity |
NPD5402 |
Approved |
0.6943 |
Remote Similarity |
NPD6099 |
Approved |
0.6943 |
Remote Similarity |
NPD6100 |
Approved |
0.6943 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.6937 |
Remote Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD920 |
Approved |
0.6933 |
Remote Similarity |
NPD3266 |
Approved |
0.6933 |
Remote Similarity |
NPD3267 |
Approved |
0.6933 |
Remote Similarity |
NPD2797 |
Approved |
0.6928 |
Remote Similarity |
NPD1296 |
Phase 2 |
0.6928 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6928 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6923 |
Remote Similarity |
NPD6111 |
Discontinued |
0.6918 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6918 |
Remote Similarity |
NPD1243 |
Approved |
0.6913 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6913 |
Remote Similarity |
NPD4359 |
Approved |
0.6908 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6901 |
Remote Similarity |
NPD5535 |
Approved |
0.6901 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6899 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6899 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6899 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6899 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6899 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.6899 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6893 |
Remote Similarity |
NPD7281 |
Phase 3 |
0.6893 |
Remote Similarity |
NPD7280 |
Phase 3 |
0.6892 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6883 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6867 |
Remote Similarity |
NPD7411 |
Suspended |
0.6867 |
Remote Similarity |
NPD6873 |
Phase 2 |
0.6864 |
Remote Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.6855 |
Remote Similarity |
NPD5958 |
Discontinued |
0.6852 |
Remote Similarity |
NPD1511 |
Approved |
0.6849 |
Remote Similarity |
NPD1894 |
Discontinued |
0.6848 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6845 |
Remote Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.6835 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6829 |
Remote Similarity |
NPD5403 |
Approved |
0.6826 |
Remote Similarity |
NPD3382 |
Approved |
0.6826 |
Remote Similarity |
NPD3383 |
Approved |
0.6826 |
Remote Similarity |
NPD3384 |
Approved |
0.6824 |
Remote Similarity |
NPD3847 |
Discontinued |
0.6818 |
Remote Similarity |
NPD3764 |
Approved |
0.6818 |
Remote Similarity |
NPD3268 |
Approved |
0.681 |
Remote Similarity |
NPD5401 |
Approved |
0.681 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6807 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6805 |
Remote Similarity |
NPD5019 |
Clinical (unspecified phase) |
0.6805 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6803 |
Remote Similarity |
NPD5691 |
Approved |
0.68 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6796 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6796 |
Remote Similarity |
NPD7235 |
Clinical (unspecified phase) |
0.6795 |
Remote Similarity |
NPD447 |
Suspended |
0.6792 |
Remote Similarity |
NPD1375 |
Discontinued |
0.679 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6788 |
Remote Similarity |
NPD4210 |
Discontinued |
0.6786 |
Remote Similarity |
NPD1358 |
Approved |
0.6772 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6772 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6772 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6768 |
Remote Similarity |
NPD1512 |
Approved |
0.6768 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6765 |
Remote Similarity |
NPD6971 |
Discontinued |
0.6755 |
Remote Similarity |
NPD1876 |
Approved |
0.6752 |
Remote Similarity |
NPD6653 |
Approved |
0.675 |
Remote Similarity |
NPD4534 |
Discontinued |
0.6747 |
Remote Similarity |
NPD4005 |
Discontinued |
0.6746 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6731 |
Remote Similarity |
NPD1240 |
Approved |
0.673 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6714 |
Remote Similarity |
NPD3134 |
Approved |
0.671 |
Remote Similarity |
NPD5109 |
Approved |
0.671 |
Remote Similarity |
NPD5110 |
Phase 2 |
0.671 |
Remote Similarity |
NPD5111 |
Phase 2 |
0.6708 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6705
|
Remote Similarity |
NPD7315 |
Approved |